EYPT NASDAQ
EyePoint Pharmaceuticals, Inc.
1W: -3.5%
1M: -10.2%
3M: -16.6%
YTD: -26.9%
1Y: +105.8%
3Y: +115.2%
5Y: +44.1%
$12.93
+0.15 (+1.17%)
Weekly Expected Move ±6.4%
$11
$12
$12
$13
$14
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$8M
Revenue
-86.4% YoY
$-272M
Net Income
-85.0% YoY
$-272M
Free Cash Flow
-79.5% YoY
24.1%
Gross Margin
-12532.5%
Op. Margin
-12188.5%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-84.5%
ROA-69.4%
ROIC-1070.4%
Valuation
P/E-4.1
P/B4.9
EV/EBITDA-3.0
Leverage
Debt/Equity0.07
Current Ratio8.88
Interest Cov.0.0x
Quality Scores
Piotroski F2/9
Altman Z5.69
Beneish M26.20